NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.7 CNY | +5.14% |
|
+7.20% | -8.67% |
| 08:33am | NKFPharma Gets Nod to Register New Cancer Treatment | MT |
| 04-27 | Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
1980393a.x8CcBFwrWkGGznJBgg5pcXpbW9Ey6ZP_BdpiGkFTXf8.o7iuYzFSCgrNpBswt1gvPxwYbrhwvKuNb7QPT3EwMsietMt0NnQsA_GNPw~433c140547b07ecef1ddddb6b1e98433
Upcoming events on Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Past events on Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
| 2024-04-26 | Q4 2023 Earnings Release |
| 2024-04-25 | Q1 2024 Earnings Release |
| 2024-01-05 01:00 | Extraordinary Shareholders Meeting |
| 2023-10-27 | Q3 2023 Earnings Release |
| 2023-08-28 | Q2 2023 Earnings Release |
| 2023-07-18 02:00 | Extraordinary Shareholders Meeting |
| 2023-05-19 02:00 | Annual General Meeting |
| 2023-04-27 | Q4 2022 Earnings Release |
| 2023-04-27 | Q1 2023 Earnings Release |
| 2023-01-15 20:30 | Extraordinary Shareholders Meeting |
| 2022-10-28 | Q3 2022 Earnings Release |
| 2022-08-29 | Interim 2022 Earnings Release |
| 2022-05-25 02:00 | Annual General Meeting |
| 2022-04-26 | FY 2021 Earnings Release |
| 2022-04-26 | Q1 2022 Earnings Release |
| 2021-10-29 | Q3 2021 Earnings Release |
| 2021-08-02 | Interim 2021 Earnings Release |
| 2021-05-17 02:00 | Annual General Meeting |
| 2021-04-26 | FY 2020 Earnings Release |
| 2021-04-26 | Q1 2021 Earnings Release |
Past dividends on Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
| 2023-07-06 | Annual 0.115 CNY |
| 2022-07-10 | Annual 0.15 CNY |
| 2021-07-14 | Annual 0.15 CNY |
| 2020-07-22 | Annual 0.3 CNY |
| 2019-07-09 | Annual 0.15 CNY |
| 2018-04-02 | Annual 0.15 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 2 470 2 516 -1.83% | 2 915 3 245 -10.16% | 3 687 3 902 -5.52% | 3 713 3 879 -4.28% | 3 931 4 223 -6.9% | 4 373 |
|
EBITDA Million CNY | Released Forecast Spread | 713 751 -5.12% | 1 021 1 138 -10.28% | 1 275 1 441 -11.49% | 1 313 1 407 -6.65% | 0,00 1 435 - | 1 251 |
|
EBIT Million CNY | Released Forecast Spread | 668 655 1.9% | 877 940 -6.72% | 1 182 1 242 -4.87% | 1 174 1 326 -11.49% | -295 1 213 -124.3% | 1 031 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 680 665 2.3% | 915 949 -3.65% | 1 204 1 267 -5.01% | 1 185 1 350 -12.18% | -295 1 228 -124.01% | 1 031 |
|
Net income Million CNY | Released Forecast Spread | 605 596 1.48% | 806 843 -4.37% | 1 059 1 124 -5.78% | 1 091 1 188 -8.22% | -189 1 107 -117.11% | 923 |
|
EPS CNY | Released Forecast Spread | 0,38 0,38 1.2% | 0,51 0,53 -3.33% | 0,68 0,71 -4.14% | 0,67 0,74 -8.84% | -0,12 0,69 -117.48% | 0,57 |
| Announcement Date | 29/04/20 | 26/04/21 | 26/04/22 | 27/04/23 | 26/04/24 | - |
| Today 16:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| Today 16:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-01 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 2024-05-01 | AMGEN INC.: Q1 2024 Earnings Release |
| 2024-05-02 01:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:30 | ORGANON & CO.: Q1 2024 Earnings Release |
| 2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 2024-05-02 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
Past sector events for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603707 Stock
- Calendar Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
